- Home
- ETON vs ACNB Comparison
ETON vs ACNB Comparison
Compare ETON & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ACNB
- Stock Information
- Founded
- ETON 2017
- ACNB 1857
- Country
- ETON United States
- ACNB United States
- Employees
- ETON N/A
- ACNB N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- ETON Health Care
- ACNB Finance
- Exchange
- ETON Nasdaq
- ACNB Nasdaq
- Market Cap
- ETON 388.3M
- ACNB 450.1M
- IPO Year
- ETON 2018
- ACNB N/A
- Fundamental
- Price
- ETON $14.39
- ACNB $41.95
- Analyst Decision
- ETON Strong Buy
- ACNB Strong Buy
- Analyst Count
- ETON 3
- ACNB 4
- Target Price
- ETON $29.67
- ACNB $50.00
- AVG Volume (30 Days)
- ETON 420.1K
- ACNB 20.0K
- Earning Date
- ETON 08-07-2025
- ACNB 07-24-2025
- Dividend Yield
- ETON N/A
- ACNB 3.29%
- EPS Growth
- ETON N/A
- ACNB N/A
- EPS
- ETON N/A
- ACNB 2.69
- Revenue
- ETON $48,327,000.00
- ACNB $123,053,000.00
- Revenue This Year
- ETON $101.12
- ACNB $40.18
- Revenue Next Year
- ETON $45.71
- ACNB $4.83
- P/E Ratio
- ETON N/A
- ACNB $15.37
- Revenue Growth
- ETON 40.88
- ACNB 15.31
- 52 Week Low
- ETON $3.25
- ACNB $35.37
- 52 Week High
- ETON $21.48
- ACNB $50.72
- Technical
- Relative Strength Index (RSI)
- ETON 45.76
- ACNB 41.49
- Support Level
- ETON $13.78
- ACNB $40.80
- Resistance Level
- ETON $15.73
- ACNB $44.05
- Average True Range (ATR)
- ETON 0.75
- ACNB 0.82
- MACD
- ETON -0.01
- ACNB -0.23
- Stochastic Oscillator
- ETON 31.98
- ACNB 26.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.